Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data-Reference-Cited by-同舟云学术

Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data

Author:

Adambekov Shalkar¹^ORCID,Lopa Samia²,Edwards Robert P.²³,Lemon Lara²⁴,Wang Shu⁵⁶^ORCID,Taylor Sarah E.²,Orr Brian²,Linkov Faina¹²³⁷⁸

Affiliation:

1. Department of Epidemiology Graduate School of Public Health University of Pittsburgh Pittsburgh PA USA

2. Department of Obstetrics, Gynecology and Reproductive Sciences University of Pittsburgh School of Medicine Pittsburgh PA USA

3. UPMC Hillman Cancer Center Pittsburgh PA USA

4. Department of Clinical Analytics University of Pittsburgh Medical Center Pittsburgh PA USA

5. University of Florida Health Cancer Center Gainesville FL USA

6. Department of Biostatistics University of Florida Gainesville FL USA

7. McGowan Institute for Regenerative Medicine Pittsburgh PA USA

8. Department of Health Administration and Public Health John G. Rangos, Sr. School of Health Sciences Duquesne University Pittsburgh PA USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

Reference32 articles.

1. SEER.Cancer stat facts: ovarian cancer.2019.https://seer.cancer.gov/statfacts/html/ovary.html. Accessed August 29 2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of BRCA Gene Testing on Ovarian Cancer Management;European Journal of Medical and Health Sciences;2022-09-20